Education Sessions by Track
Please use the track listing to help locate which sessions may be of interest to you. Education sessions fall into multiple tracks so you may see them listed more than once.
Many of the education tracks correspond to a Certified Pharmaceutical Industry Professional™ (CPIP™) Knowledge Element. CPIP is a competency-based international credential.
Important Information About ISPE's Education Programs
Survival
The theme of this year’s ISPE Annual Meeting is Thriving in a Survival Environment. ISPE education sessions are created by ISPE Members who work every day in the same environment that you work and face similar challenges. As Volunteers, ISPE Member presenters bring their good ideas to the Annual Meeting table sharing knowledge, insight and application through these education sessions, aiming to strengthen the pharma environment through this medium. This track has a lot to offer! Sessions include:
- 103 - Combination Products: Considerations for Entering a New Market
- 104 - Risk Assessment and Risk Management
- 105 - Building Yourself an Ark: Tools for Controlling Stress to Help Workers Thrive and Survive in the Workplace
- 106 - Logistics: Follow the Money/Material and the Impact on Unit Pricing
- 201 - LEAN Quality: Applying Lean Thinking to Quality Systems & a Case Study: LEAN within Quality Assurance/ Quality Control at H. Lundbeck A/S
- 203 - Survival - From Manufacturer’s Perspective
- 207 - Profitability through Sustainable Design [Green = Profit]
- 303 - Ensuring the Integrity of the Global Supply Chain
- 404 - Anticounterfeiting – Can Chemistry Trump Bureaucracy?
- 405 - Driving Improvement for Bioprocessing Operations
- 407 - Current Outsourcing Trends in Bio-contract Manufacturing: The Impact on Pharmaceutical Engineers’ Productivity and Job Security
- 502 - Sustainability for Biotech Processes
- 505 - Continuous Pharmaceutical Manufacturing – Opportunities Now and in the Future
- 506 - Sustainable Projects for Existing Facilities [Green = Profit]
- 604 - Meeting Regulatory Need: The Challenge for Generics and CMOs and the Risk of Ignoring Warning Letters - Cancelled
- 606 - 21st Century Approaches for Reducing Manufacturing Costs During a Global Economic Crisis
- All of Project Management:
Product Development (CPIP Knowledge Element 1)
CPIP knowledge element one includes: formulation, clinical phases, and manufacture; technology transfer; production scale-up and optimization. Sessions in this track feature content in these areas. Sessions include:
- 102 - New Technologies in OSD
- 103 - Combination Products: Considerations for Entering a New Market
- 104 - Risk Assessment and Risk Management
- 107 - Implementing Quality Risk Management: Using Risk Assessment to Speed Your Way to Drug Approvals
- 201 - LEAN Quality: Applying Lean Thinking to Quality Systems & a Case Study: LEAN within Quality Assurance /Quality Control at H. Lundbeck A/S
- 203 - Survival - From Manufacturer’s Perspective
- 206 - Process Analytical Technology (PAT) Used for PQLI® and QbD: Implementation Update, Examples, and Discussion
- 207 - Profitability through Sustainable Design [Green = Profit]
- 301 - Quality and Regulatory Challenges Relating to Development, Use, and Approval of Drugs for Medical Countermeasures
- 401 - A Seamless Approach for Technology Transfer
- 405 - Driving Improvement for Bioprocessing Operations
- 502 - Sustainability for Biotech Processes
- 505 - Continuous Pharmaceutical Manufacturing – Opportunities Now and in the Future
- 507 - Advanced Aseptic Processing
- 606 - 21st Century Approaches for Reducing Manufacturing Costs During a Global Economic Crisis
- 609 - Why the New OSD Guide is Vital
Facilities and Equipment (CPIP Knowledge Element 2)
CPIP knowledge element two includes: design and construction/installation; commissioning and qualification as a risk management strategy; operation and maintenance; controls and automation. Sessions include:
- 101 - Facility of the Year Category Award Winner Presentations
- 104 - Risk Assessment and Risk Management
- 202 - Case Study: Cephalon Master Plan and Renovation of Corporate R & D Headquarters, Westchester, PA, USA
- 204 - Good Engineering Practice
- 207 - Profitability through Sustainable Design [Green = Profit]
- 302 - C&Q COP Pharma Manufacturers Risk Approach Task Team Forum
- 304 - Case Studies in Contained Active Pharmaceutical Ingredients (API) Pilot and Manufacturing Facilities
- 402 - Disposable Manufacturing Strategies, Impact on Design, Operations and the Environment
- 405 - Driving Improvement for Bioprocessing Operations|
- 502 - Sustainability for Biotech Processes
- 504 - The New NIH Design Requirements Manual for State-of-the-Art Biomedical Research Facilities
- 505 - Continuous Pharmaceutical Manufacturing – Opportunities Now and in the Future
- 602 - Critical Utilities – Guides, Hot Topics, and Sustainable Design
- 607 - The New Maintenance Good Practice Guide
- All of Project Management:
Information Systems (CPIP Knowledge Element 3)
Sessions include:
- 403 - Infrastructure Compliance Lifecycle
- 503 - Dispelling the Part 11 Myths
- 603 - Life After GAMP® 5: What Comes Next?
Supply Chain Management (CPIP Knowledge Element 4)
CPIP knowledge element four includes: materials management; operational economics; warehouse and distribution management. Sessions include:
- 106 - Logistics: Follow the Money/Material and the Impact on Unit Pricing
- 203 - Survival - From Manufacturer’s Perspective
- 303 - Ensuring the Integrity of the Global Supply Chain
- 402 - Disposable Manufacturing Strategies, Impact on Design, Operations and the Environment
- 404 - Anticounterfeiting – Can Chemistry Trump Bureaucracy?
- 407 - Current Outsourcing Trends in Bio-contract Manufacturing: The Impact on Pharmaceutical Engineers’ Productivity and Job Security
- 700 - Investigational Products – Innovation in a Regulated Environment
Production Systems (CPIP Knowledge Element 5)
CPIP knowledge element five includes: production unit operations - drug (small molecule) and biologics; production management; production control. Sessions include:
- 102 - New Technologies in OSD
- 202 - Case Study: Cephalon Master Plan and Renovation of Corporate R & D Headquarters, Westchester, PA, USA
- 203 - Logistics: Follow the Money/Material and the Impact on Unit Pricing
- 204 - Good Engineering Practice
- 304 - Case Studies in Contained Active Pharmaceutical Ingredients (API) Pilot and Manufacturing Facilities
- 402 - Disposable Manufacturing Strategies, Impact on Design, Operations and the Environment
- 405 - Driving Improvement for Bioprocessing Operations
- 407 - Current Outsourcing Trends in Bio-contract Manufacturing: The Impact on Pharmaceutical Engineers’ Productivity and Job Security
- 504 - The New NIH Design Requirements Manual for State-of-the-Art Biomedical Research Facilities
- 506 - Sustainable Projects for Existing Facilities [Green = Profit]
- 507 - Advanced Aseptic Processing
- 602 - Critical Utilities – Guides, Hot Topics, and Sustainable Design
- 604 - Meeting Regulatory Need: The Challenge for Generics and CMOs and the Risk of Ignoring Warning Letters - Cancelled
- 607 - The New Maintenance Good Practice Guide
- 609 - Why the New OSD Guide is Vital
Regulatory Compliance (CPIP Knowledge Element 6)
CPIP knowledge element six includes: government regulations; standards, practices, and guides. Sessions include:
- 103 - Combination Products: Considerations for Entering a New Market
- 205 - Regulatory Hot Topics - Town Hall Forum
- 206 - Process Analytical Technology (PAT) used for PQLI® and QbD: Implementation Update, Examples, and Discussion
- 301 - Quality and Regulatory Challenges Relating to Development, Use, and Approval of Drugs for Medical Countermeasures
- 302 - C&Q COP Pharma Manufacturers Risk Approach Task Team Forum
- 303 - Ensuring the Integrity of the Global Supply Chain
- 305 - Product Quality Lifecycle Implementation (PQLI®): Regional Regulatory Experiences Implementing the ICH Quality Vision
- 306 - Validation Master Plan Benefits, Application, and Case Studies
- 403 - Infrastructure Compliance Lifecycle
- 404 - Anticounterfeiting – Can Chemistry Trump Bureaucracy?
- 406 - Product Quality Lifecycle Implementation (PQLI®): Focusing on Q10
- 503 - Dispelling the Part 11 Myths
- 504 - The New NIH Design Requirements Manual for State-of-the-Art Biomedical Research Facilities
- 505 - Continuous Pharmaceutical Manufacturing – Opportunities Now and in the Future
- 603 - Life After GAMP® 5: What Comes Next?
- 604 - Meeting Regulatory Need: The Challenge for Generics and CMOs and the Risk of Ignoring Warning Letters - Cancelled
- 605 - Validating per Annex 1
Quality Systems (CPIP Knowledge Element 7)
CPIP knowledge element seven includes: risk management and Quality Management System (QMS); systems validation. Sessions include:
- 104 - Risk Assessment and Risk Management
- 107 - Implementing Quality Risk Management: Using Risk Assessment to Speed Your Way to Drug Approvals
- 201 - LEAN Quality: Applying Lean Thinking to Quality Systems & a Case Study: LEAN within Quality Assurance/ Quality Control at H. Lundbeck A/S
- 203 - Survival - From A Manufacturer’s Perspective
- 204 - Good Engineering Practice
- 205 - Regulatory Hot Topics - Town Hall Forum
- 206 - Process Analytical Technology (PAT) Used for PQLI® and QbD: Implementation Update, Examples, and Discussion
- 301 - Quality and Regulatory Challenges Relating to Development, Use, and Approval of Drugs for Medical Countermeasures
- 302 - C&Q COP Pharma Manufacturers Risk Approach Task Team Forum
- 304 - Case Studies in Contained Active Pharmaceutical Ingredients (API) Pilot and Manufacturing Facilities
- 306 - Validation Master Plan Benefits, Application, and Case Studies
- 403 - Infrastructure Compliance Lifecycle
- 404 - Anticounterfeiting – Can Chemistry Trump Bureaucracy?
- 405 - Driving Improvement for Bioprocessing Operations
- 503 - Dispelling the Part 11 Myths
- 504 - The New NIH Design Requirements Manual for State-of-the-Art Biomedical Research Facilities
- 505 - Continuous Pharmaceutical Manufacturing – Opportunities Now and in the Future
- 603 - Life After GAMP® 5: What Comes Next?
- 604 - Meeting Regulatory Need: The Challenge for Generics and CMOs and the Risk of Ignoring Warning Letters - Cancelled
- 605 - Validating per Annex 1
Investigational Products
The Investigational Products (IP) Community of Practice (COP) brings together industry professionals for interactive learning and networking opportunities. This year’s sessions include educational topics that address challenges that industry professionals face in their day-to-day lives, as well as emerging or strategic topics important for managers and decision-makers. For all programming in this track, simply register for session 700. This track’s sessions take place from Monday afternoon through Wednesday morning. Most registrants sign up for the full track, but also may wish to select sessions on Sunday afternoon and Wednesday afternoon. Please see the overall schedule for session options at those times.
700 - Innovation in a Regulated Environment includes:
- Adaptive Clinical Trials
- Optimizing the Client Vendor Relationship
- Considerations for Managing and Motivating Clinical Supplies Personnel
- Concepts for Managing Clinical Supply Inventory
- Extemporaneous Preparation of Clinical Trial Material (CTM) at the Investigational Site
- Supply Options for Investigator Sponsored Studies
- Panel: Key Success Factors and Strategies for Outsourcing
- Utilization of Simulation for Supply Forecasting (Case Studies)
- Clinical Supplies in Japan
- Options for Supplying Non-Investigational Medicinal Products
- Evolution and Future Application of Simulation
- Import/Export
- Cold Chain
- Innovative Packaging and Labeling Approaches
- Wild Card session with industry thought leaders and specialists, where attendees will have the opportunity to ask questions and gain perspectives
Project Management
The PM Community of Practice (COP) has chosen two distinct, large-scale capital projects to feature through six highly-interactive sessions for the Project Management Track. Attend the first of these sessions for an in-depth presentation of each project and then explore each of the following using the case studies as the basis for discussion and insight.
- 108 - Case Studies
- 208 - Project Conceptualization
- 307 - Better Project Results Through Innovative Collaboration and Outsourcing
- 308 - Project Design
- 408 - Project Construction
- 508 - Project Commissioning and Qualification
- 608 - Project Operations
Supplier-Focused
Suppliers are an incredibly important part of this program and offer a superb knowledge resource. This year, sessions of particular interest to suppliers are listed as a track to recognize this important facet of ISPE educational programming. Sessions include:
- 101 - Facility of the Year Category Award Winner Presentations
- 102 - New Technologies in OSD
- 202 - Case Study: Cephalon Master Plan and Renovation of Corporate R&D Headquarters, Westchester, PA, USA
- 307 - Better Project Results Through Innovative Collaboration and Outsourcing
- 402 - Disposable Manufacturing Strategies, Impact on Design, Operations and the Environment
- 505 - Continuous Pharmaceutical Manufacturing – Opportunities Now and in the Future
- 604 - Meeting Regulatory Need: The Challenge for Generics and CMOs and the Risk of Ignoring Warning Letters - Cancelled
- 607 - The New Maintenance Good Practice Guide
